BIODOL THERAPEUTICS

📍 CLAPIERS, France🗓 Founded 2015👥 7 employees💰 Last funded Jun 2020
Pharmaceutical Manufacturing🌐 biodol.eu
Website LinkedIn
BIODOL Therapeutics is a biotech company developing first-in-class compounds for treating chronic pain. It is based on the discovery by Biodols scientists of the target FLT3, which is a master hub protein in the initiation and maintenance of neuropathic pain (Nature Communications 2018). Morevover, Biodol discovered that its FLT3 breakthrough platform will also help fighting the "Opioid Crisis"​ (patented but yet unpublished). Biodol has a series of FLT3 selective small-molecule extracellular antagonists. The Biodols FLT3 technological Platform is worldwide protected by 5 patents.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2015
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Belgium
1
Frequently asked questions
Who invested in BIODOL THERAPEUTICS?
BIODOL THERAPEUTICS has 1 investors on record on gritt.io, 1 mid-stage.
When did BIODOL THERAPEUTICS last raise funding?
The most recent investment in BIODOL THERAPEUTICS recorded on gritt.io was in June 2020.
When was BIODOL THERAPEUTICS founded?
BIODOL THERAPEUTICS was founded in 2015.
What industry is BIODOL THERAPEUTICS in?
BIODOL THERAPEUTICS operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is BIODOL THERAPEUTICS based?
BIODOL THERAPEUTICS is headquartered in CLAPIERS, France.